Fluoxetine and dothiepin therapy in primary care and health resource utilization: Evidence from the United Kingdom

International Journal of Psychiatry in Clinical Practice

Volumn 3, Issue 1, 1999, Pages 23-30

  Treglia, Michael ^a   Neslusan, Cheryl A ^b,c   Dunn, Rodney L ^b,c  

^a ELI LILLY AND COMPANY   (United States)

^b MEDSTAT GROUP   (United States)

^c MEDSTAT Group   (United States)

Author keywords

Antidepressants; Depression; Healthcare resources; Selective serotonin re uptake inhibitors; Tricyclics

Indexed keywords

ANTIDEPRESSANT AGENT; DOSULEPIN; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; CLINICAL PRACTICE; DEPRESSION; ECONOMIC ASPECT; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

EID: 0032936436     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509909024755     Document Type: Review

References (23)

1. Greenberg PE, Saiglin LE, Finkelstein SN, Berndt ER (1993) The economic burden of depression in 1990. J Clin Psychiatry 54: 405-18.
2. Kind P, Sorensen J (1993) The costs of depression. Int Clin Psychopharmacol 7: 191-5.
3. British Association for Psychopharmacology (1993) Guidelines for treating depressive illness with antidepressants. J Psychopharmacol 7: 19-23.
4. Hotopf M, Lewis G, Normand C (1996) Are SSRIs a cost-effective alternative to tricyclics? Br J Psychiatry 168: 404-9.
5. Song F, Freemantle N, Sheldon TA (1994) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br Med J 306: 683-7.
6. Donoghue JM, Tylee A, Wildgust H (1996) Cross-sectional database analysis of antidepressant prescribing in general practice in the United Kingdom. Br Med J 313: 811-2.
7. Donoghue JM, Tylee A (1996). The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 168: 164-8.
8. MacDonald TM, McMahon AD, Reid IC et al (1996) Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. Br Med J 313: 860-1.
9. Gillings D, Koch G (1991) The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Info J 25: 411-24.
10. Simon GE, Von Korff M, Heiligenstein JH et al (1996) Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs. tricyclic antidepressants. JAMA 275: 1897-1902.
11. Terza J (1998) Estimating count data models with endogenous switching: sample selection and endogenous treatment effects. J Econometrics 84: 129-54.
12. Agency for Health Care Policy Research (1993) Treatment of major depression: clinical practice guidelines. US Department of Health and Human Services, AHCPR Publication 93-0550. 1(5).
13. Ashcraft MLF, Fries BE, Nerenz DR et al (1989) A psychiatric patient classification system: An alternative to diagnoses-related groups. Med Care 27: 543-57.
14. Simon GE, Fishman P (1998) Cost implications of initial antidepressant selection in primary care. Pharmacoeconomics 13: 61-70.
15. Heckman J (1976) The common structure of statistical models of truncation, sample selection and limited dependent variables and a simple estimator for such models. Ann Econ Soc Meas 5: 475-92.
16. Greene WH (1974) Econometric Analysis. Macmillan, New York.
17. Croghan TW, Lair TJ, Engelhart L et al (1997) Effect of antidepressant therapy on health care utilization and costs in primary care. Psychiatric Services 48: 1420-6.
18. Hylan TR, Crown WH, Meneades L et al (1998) Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis. J Affective Disord 47: 71-9.
19. Crown WH, Hylan TR, Meneades L (1998) Antidepressant selection and use and healthcare expenditures. Pharmacoeconomics 13: 435-48.
20. Simon G, Wagner E, Von Korf M (1995) Cost-effectiveness comparisons using "real world" randomized trials: The case of new antidepressant drugs. J Clin Epidemiol 48: 363-73.
21. Sclar DA, Robison LM, Skaer TL et al (1994) Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization. Clin Ther 16: 715-30.
22. Sclar DA, Skaer TL, Robison LM et al (1998) Economic outcomes with antidepressant pharmacotherapy: A retrospective intent-to-treat analysis. J Clin Psychiatry 59 (suppl 2): 13-17.
23. Netten A, Dennett J (1996) Unit costs of health & social care. Personal Social Services Research Unit, University of Kent at Canterbury.